Immune stress suppresses innate immune signaling in preleukemic precursor B-cells to provoke leukemia in predisposed mice.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
24 08 2023
Historique:
received: 18 01 2023
accepted: 17 08 2023
medline: 28 8 2023
pubmed: 25 8 2023
entrez: 24 8 2023
Statut: epublish

Résumé

The initial steps of B-cell acute lymphoblastic leukemia (B-ALL) development usually pass unnoticed in children. Several preclinical studies have shown that exposure to immune stressors triggers the transformation of preleukemic B cells to full-blown B-ALL, but how this takes place is still a longstanding and unsolved challenge. Here we show that dysregulation of innate immunity plays a driving role in the clonal evolution of pre-malignant Pax5

Identifiants

pubmed: 37620322
doi: 10.1038/s41467-023-40961-z
pii: 10.1038/s41467-023-40961-z
pmc: PMC10449887
doi:

Substances chimiques

Myeloid Differentiation Factor 88 0
Adaptor Proteins, Signal Transducing 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

5159

Informations de copyright

© 2023. Springer Nature Limited.

Références

Blood. 2020 Oct 29;136(18):2003-2017
pubmed: 32911536
Cell. 2019 Sep 5;178(6):1313-1328.e13
pubmed: 31491384
Cancer Res. 2008 Aug 15;68(16):6803-9
pubmed: 18701506
Chem Biol Interact. 2012 Apr 5;196(3):102-9
pubmed: 21352818
Clin Cancer Res. 2005 Oct 15;11(20):7209-19
pubmed: 16243790
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Cancer Res. 2022 Mar 15;82(6):1098-1109
pubmed: 35131871
Nat Biotechnol. 2019 Aug;37(8):852-857
pubmed: 31341288
Bioinformatics. 2012 Feb 1;28(3):311-7
pubmed: 22155872
Nat Genet. 2013 Oct;45(10):1226-1231
pubmed: 24013638
Bioinformatics. 2012 Sep 15;28(18):i333-i339
pubmed: 22962449
Nat Immunol. 2015 Jul;16(7):766-774
pubmed: 25985233
Blood Cancer J. 2013 Oct 11;3:e151
pubmed: 24121163
Nat Commun. 2019 Dec 5;10(1):5563
pubmed: 31804490
Leukemia. 2017 Aug;31(8):1819-1821
pubmed: 28446785
Nucleic Acids Res. 2002 Jul 15;30(14):3059-66
pubmed: 12136088
Leukemia. 2008 Jan;22(1):189-93
pubmed: 17690702
Nat Rev Cancer. 2018 Aug;18(8):471-484
pubmed: 29784935
Nucleic Acids Res. 2002 Jan 1;30(1):207-10
pubmed: 11752295
EMBO J. 2018 Jul 13;37(14):
pubmed: 29880602
Nat Biotechnol. 2013 Mar;31(3):213-9
pubmed: 23396013
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Nature. 2007 Sep 27;449(7161):473-7
pubmed: 17851532
Proc Natl Acad Sci U S A. 2011 Feb 15;108(7):2873-8
pubmed: 21282644
Bioinformatics. 2010 Mar 1;26(5):589-95
pubmed: 20080505
Lancet. 1988 Dec 10;2(8624):1323-7
pubmed: 2904050
Trends Cancer. 2022 Nov;8(11):887-889
pubmed: 35871053
Cancer Res. 2017 Aug 15;77(16):4365-4377
pubmed: 28630052
EMBO J. 2012 Jun 05;31(14):3130-46
pubmed: 22669466
Cancer Discov. 2015 Dec;5(12):1328-43
pubmed: 26408659
Nat Rev Cancer. 2022 Jul;22(7):397-413
pubmed: 35355007
ISME J. 2012 Mar;6(3):610-8
pubmed: 22134646
Cancer Res. 2018 May 15;78(10):2669-2679
pubmed: 29490943
Nature. 2001 Oct 18;413(6857):732-8
pubmed: 11607032
Genome Biol. 2016 Aug 24;17(1):178
pubmed: 27557938
Br J Cancer. 2011 Nov 22;105(11):1783-7
pubmed: 22027710
Genome Biol. 2014 Jun 26;15(6):R84
pubmed: 24970577
Immunol Today. 1998 Oct;19(10):480-5
pubmed: 9785673
Leukemia. 2004 Jan;18(1):63-71
pubmed: 14603332
Bioinformatics. 2016 Apr 15;32(8):1220-2
pubmed: 26647377
PLoS Comput Biol. 2016 Apr 21;12(4):e1004873
pubmed: 27100738
Infect Immun. 2006 Mar;74(3):1462-70
pubmed: 16495516
Genome Res. 2017 Dec;27(12):2050-2060
pubmed: 29097403
Nat Genet. 2003 Jul;34(3):267-73
pubmed: 12808457
Nat Rev Immunol. 2021 Sep;21(9):570-581
pubmed: 33558682
J Clin Oncol. 2007 Apr 10;25(11):1341-9
pubmed: 17312329
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Br J Haematol. 2020 Jul;190(2):262-273
pubmed: 32118299
Eur J Microbiol Immunol (Bp). 2013 Mar;3(1):1-10
pubmed: 24265914
Immunity. 1998 Jul;9(1):143-50
pubmed: 9697844
Am J Epidemiol. 2015 Apr 15;181(8):549-62
pubmed: 25731888
Leukemia. 2016 Oct;30(10):2116-2119
pubmed: 27220664
Nat Commun. 2017 Jan 24;8:14061
pubmed: 28117401
Immunity. 2007 Jul;27(1):49-63
pubmed: 17658281
Br J Cancer. 2015 Mar 17;112(6):1017-26
pubmed: 25675150
Exp Hematol. 2019 May;73:7-12.e4
pubmed: 30825516
Int J Epidemiol. 2010 Jun;39(3):718-32
pubmed: 20110276
Genome Biol. 2011 Jun 24;12(6):R60
pubmed: 21702898
Leukemia. 1988 Feb;2(2):120-5
pubmed: 3278171
Appl Environ Microbiol. 2005 Dec;71(12):8228-35
pubmed: 16332807
Nat Methods. 2018 Aug;15(8):591-594
pubmed: 30013048
PLoS One. 2010 Mar 10;5(3):e9490
pubmed: 20224823
Cell. 1994 Dec 2;79(5):901-12
pubmed: 8001127
J Clin Invest. 2009 Apr;119(4):826-36
pubmed: 19287094
Microbiome. 2018 May 17;6(1):90
pubmed: 29773078
Blood. 2021 Mar 11;137(10):1424-1428
pubmed: 33036026
Leukemia. 2021 May;35(5):1258-1264
pubmed: 33833382
Nat Methods. 2015 Oct;12(10):966-8
pubmed: 26258291
Leukemia. 2014 May;28(5):1136-8
pubmed: 24287434
Genome Res. 2012 Mar;22(3):568-76
pubmed: 22300766
Appl Environ Microbiol. 2007 Mar;73(5):1576-85
pubmed: 17220268
JAMA Pediatr. 2015 Jun;169(6):e151025
pubmed: 26030516

Auteurs

Marta Isidro-Hernández (M)

Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno s/n, Salamanca, Spain.
Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.

Ana Casado-García (A)

Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno s/n, Salamanca, Spain.
Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.

Ninad Oak (N)

Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Silvia Alemán-Arteaga (S)

Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno s/n, Salamanca, Spain.
Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.

Belén Ruiz-Corzo (B)

Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno s/n, Salamanca, Spain.
Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.

Jorge Martínez-Cano (J)

Immune system development and function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain.

Andrea Mayado (A)

Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Servicio de Citometría, Departamento de Medicina, Biomedical Research Networking Centre on Cancer CIBER-CIBERONC (CB16/12/00400), Institute of Health Carlos III, and Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Salamanca, Spain.

Elena G Sánchez (EG)

Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain.

Oscar Blanco (O)

Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Departamento de Anatomía Patológica, Universidad de Salamanca, Salamanca, Spain.

Ma Luisa Gaspar (ML)

Immunobiology Department, Carlos III Health Institute, 28220, Majadahonda (Madrid), Spain.

Alberto Orfao (A)

Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Servicio de Citometría, Departamento de Medicina, Biomedical Research Networking Centre on Cancer CIBER-CIBERONC (CB16/12/00400), Institute of Health Carlos III, and Instituto de Biología Molecular y Celular del Cáncer, CSIC/Universidad de Salamanca, Salamanca, Spain.

Diego Alonso-López (D)

Bioinformatics Unit, Cancer Research Center (CSIC-USAL), Salamanca, Spain.

Javier De Las Rivas (J)

Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Bioinformatics and Functional Genomics Research Group, Cancer Research Center (CSIC-USAL), Salamanca, Spain.

Susana Riesco (S)

Department of Pediatrics, Hospital Universitario de Salamanca, Paseo de San Vicente, 58-182, Salamanca, 37007, Spain.

Pablo Prieto-Matos (P)

Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Department of Pediatrics, Hospital Universitario de Salamanca, Paseo de San Vicente, 58-182, Salamanca, 37007, Spain.

África González-Murillo (Á)

Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain.

Francisco Javier García Criado (FJG)

Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Departamento de Cirugía, , Universidad de Salamanca, Salamanca, Spain.

María Begoña García Cenador (MBG)

Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
Departamento de Cirugía, , Universidad de Salamanca, Salamanca, Spain.

Manuel Ramírez-Orellana (M)

Department of Pediatric Hematology and Oncology, Hospital Infantil Universitario Niño Jesús, Universidad Autónoma de Madrid, Madrid, Spain.

Belén de Andrés (B)

Immunobiology Department, Carlos III Health Institute, 28220, Majadahonda (Madrid), Spain.

Carolina Vicente-Dueñas (C)

Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. cvd@usal.es.
Department of Pediatrics, Hospital Universitario de Salamanca, Paseo de San Vicente, 58-182, Salamanca, 37007, Spain. cvd@usal.es.

César Cobaleda (C)

Immune system development and function Unit, Centro de Biología Molecular Severo Ochoa (Consejo Superior de Investigaciones Científicas -Universidad Autónoma de Madrid), Madrid, Spain. cesar.cobaleda@csic.es.

Kim E Nichols (KE)

Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN, USA. Kim.Nichols@STJUDE.ORG.

Isidro Sánchez-García (I)

Experimental Therapeutics and Translational Oncology Program, Instituto de Biología Molecular y Celular del Cáncer, CSIC-USAL, Campus M. de Unamuno s/n, Salamanca, Spain. isg@usal.es.
Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. isg@usal.es.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH